Studies have demonstrated that VEGF binding to its receptor can inhibit the maturation and antigen presentation process of dendritic cells, and simultaneously induce the expression of PD-L1 receptor on the surface of the cells, thereby inhibiting the killing effect of the immune system on tumor cells [12]. The gene discussed is VEGFA; the disease is neoplasm.